Učitavanje...

A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia

OBJECTIVE: To evaluate the effectiveness of lurasidone as maintenance treatment for schizophrenia. METHOD: Adults experiencing an acute exacerbation of schizophrenia initially received 12–24 weeks of open-label treatment with lurasidone (40–80 mg/d, flexibly dosed). Patients who maintained clinical...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Psychopharmacol
Glavni autori: Tandon, Rajiv, Cucchiaro, Josephine, Phillips, Debra, Hernandez, David, Mao, Yongcai, Pikalov, Andrei, Loebel, Antony
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2016
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4717319/
https://ncbi.nlm.nih.gov/pubmed/26645209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0269881115620460
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!